Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion agreement to acquire Forma Therapeutics, and its therapeutic candidate etavopivat, in phase ...

Monthly fluctuation during the last 30 days as follows for BHD to PKR: High PKR 753.5 and Low PKR 746.85 in value, where buying was PKR 737.40 and Selling 745.40 Pakistan and Bahrain are both Islamic ...